SGO
SGO
  • Daily Coverage
  • Photo Gallery
  • Meeting Program
  • Registration
Topics
  • Daily Coverage
  • Photo Gallery
  • Meeting Program
  • Registration
Facebook iconInstagram iconTwitter X icon LinkedIn icon
Mar 16th, 2025

Streamlining Surgery to Enhance Outcomes

Rise of de-escalation trends requires educational shift to transform disease management.


Alexa Kanbergs, MD-ScM, MS
Alexa Kanbergs, MD-ScM, MS

Surgical strategies and procedural techniques have historically advanced over time and continue to do so, particularly in oncologic disease management. Only recently have de-escalation trends emerged in gynecologic oncology and, even more recently, been evaluated to understand the impact on physicians and patients.

Alexa Kanbergs, MD-ScM, MS, a gynecologic oncology fellow at MD Anderson Cancer Center in Houston, presented “Surgical de-escalation within gynecologic oncology” yesterday.

Identifying the Trend

The purpose of surgical de-escalation is to make interventions — when needed — less invasive, thereby minimizing damage, reducing risk of complications, and improving patient outcomes. It is a practice that has become more firmly rooted and regulated in other oncology specialties and medical fields, said Dr. Kanbergs.

“Historically, cancer treatment paradigms prioritized maximal surgical resection to ensure oncologic control. The belief was that more extensive surgery correlated with better survival outcomes,” she said.

Innovations in technology have allowed for more precise imaging and defined molecular pathology, Dr. Kanbergs said, as well as a deeper understanding of tumor biology. This progress, along with available targeted drug treatments and immunotherapy, is leading the way to “personalize cancer management.”

Due to the extensive time and cost of surgical trials, this was the first of its kind to research the in-depth impact the revolutionary shift has had on surgeons and their educators.

The study, which was published in JAMA Network Open, analyzed data of 1,218,490 patients from the National Center Database (NCDB) who were diagnosed with clinical stage I-IV endometrial, ovarian, cervical, or vulvar cancer between Jan. 1, 2004, and Dec. 31, 2020.

In the 16-year time period, the clinical researchers observed a decrease in the number of people undergoing oncologic surgeries and an increase in the use of laparoscopic techniques and other minimally invasive methods, confirming the move toward surgical de-escalation. They also saw higher adoption of sentinel lymph node dissection and a reduction in complete lymphadenectomy in all cancer types except for ovarian cancer.

“For me, the most surprising finding was the limited percentage of patients with low-risk endometrial cancer who had ovarian preservation,” Dr. Kanbergs said. “This was unexpected, given current guidelines provide support for ovarian preservation in low-risk cases.”

Filling the Knowledge Gap

These results indicate a strong trend in the right direction in the first two decades of the 21st century. However, according to Dr. Kanbergs, a recent survey assessed the readiness of gynecologic oncology graduates. Approximately three-fourths (76%) of new physicians admitted feeling comfortable to perform a radical hysterectomy, and only 60% said they felt confident to complete a laparoscopic para-aortic lymphadenectomy.

“De-escalation strategies have significant implications. For physicians, it necessitates an evolution in surgical training and daily practice,” she said. “As certain procedures become less common, maintaining proficiency in more radical surgeries becomes a challenge, particularly for trainees and early-career gynecologic oncologists.”

Dr. Kanbergs said more research is required to better grasp the full impact and implementation of surgical de-escalation trends within gynecologic oncology, and she hopes attendees take away this particular call to action.

“As the field shifts toward less invasive techniques, it is essential to ensure that the next generation of gynecologic oncologists is still adequately trained in more complex, rare, or radical procedures,” she said.

Now armed with this base knowledge, researchers can also dedicate future studies to examining the correlation between the trends and patient outcomes, such as safety, adverse events, recovery, quality of life, and satisfaction measures. Equitable access to care is also an important factor to analyze and ensure as surgical de-escalation continues to grow, Dr. Kanbergs said.

Interesting Stories
View the current issue of Gynecologic Oncology
Sponsored by SGO
View the current issue of Gynecologic Oncology
Coding Corner: Intra-abdominal Tumor Excision or Destruction Code Changes
Sponsored by SGO
Coding Corner: Intra-abdominal Tumor Excision or Destruction Code Changes
Learn More About Wellness Programs
Sponsored by SGO
Learn More About Wellness Programs
More Content
Sgo Annual Meeting Saturday Photo By Fwc Awards
Home
FWC Research & Grant Recipients
Mar 17th, 2025
San Juan, Puerto Rico
Home
Save the date for SGO 2026 Annual Meeting on Women’s Cancer
Mar 17th, 2025
Karen Lu, MD
Home
Get to Know SGO’s Incoming President
Mar 17th, 2025
Sgo Annual Meeting Friday Photo By Nick Klein Awards
Home
SGO and FWC Leadership Award Winners
Mar 17th, 2025
audience shot
Home
A Potential New Detection Tool for Invasive Cervical Cancer
Mar 16th, 2025
Ginger Gardner, MD, FACOG
Home
Empowering Progress: The Foundation for Women's Cancer
Mar 16th, 2025
Lead 3
Home
Shaping the Next Generation of Leaders
Mar 16th, 2025
headshot of Dr. Choi
Daily Coverage
A Potential Second-Line Treatment for Cervical Cancer
Mar 15th, 2025
Tamar Gootzen, MD
Home
An Alternative Approach to Preventing Ovarian Cancer?
Mar 15th, 2025
Fang Jiang, MD, PhD
Home
Changing the Course for First-Line, Low-Risk Gestational Trophoblastic Neoplasia
Mar 15th, 2025
Angela Nolin, MD
Home
It’s Time to Change the Diagnosis Protocol for Endometrial Cancer
Mar 15th, 2025
Kathleen N. Moore, MD
Home
Durvalumab Plus Carboplatin and Paclitaxel Delivers One-Two Punch for Endometrial Cancer Treatment
Mar 14th, 2025
SGO
Facebook iconInstagram iconTwitter X icon LinkedIn icon
© 2025 Ascend Media. All rights reserved.